Cortexa Genomix Inc Information

Cortexa Genomix Inc. is a Toronto-based precision diagnostics company developing advanced computational platforms to transform complex multi-omics data into clinically actionable disease risk insights. Our platform integrates genomics, transcriptomics, proteomics, metabolomics, and clinical data to enable earlier, more accurate, and more interpretable disease risk prediction. Designed to operate at scale, the system supports diverse high-dimensional data sources—including RNA-seq, SNPs, sequence data, and public repositories such as GEO—and provides researchers and clinicians with robust computational tools to decode biological complexity and support effective prognostics. Cortexa’s technology combines machine learning–driven feature engineering, pathway-level aggregation, graph-based biological modeling, and visualization to move beyond black-box analytics. By leveraging scalable architectures and graph technologies such as Neo4j and MongoDB, we bridge the gap between raw sequencing data and biologically interpretable, clinically relevant outcomes—supporting validation, reproducibility, and regulatory readiness. Our initial application focus includes fertility, oncology, and neurological disorders, where early detection and mechanistic insight can significantly improve patient outcomes. Built and validated in Ontario through academic, clinical, and industry collaboration, Cortexa Genomix is advancing toward validated, AI-enabled diagnostic solutions that support a transition from reactive treatment to predictive, personalized healthcare.